Cancers (Sep 2022)

Clinical Effectiveness of Faecal Immunochemical Test in the Early Detection of Colorectal Cancer—An Umbrella Review

  • Jakub Świtalski,
  • Tomasz Tatara,
  • Katarzyna Wnuk,
  • Wojciech Miazga,
  • Dagmara Karauda,
  • Adrian Matera,
  • Magdalena Jabłońska,
  • Sylwia Jopek,
  • Urszula Religioni,
  • Mariusz Gujski

DOI
https://doi.org/10.3390/cancers14184391
Journal volume & issue
Vol. 14, no. 18
p. 4391

Abstract

Read online

Introduction: The colorectal cancer prognosis depends on the stage of the neoplasm; therefore, its early detection plays an important role. The aim of the study is evaluation of the sensitivity, specificity, and clinical effectiveness of the faecal immunochemical test in the early colorectal cancer detection. Methods: The clinical analysis was based on the results of the studies included in a systematic review conducted in accordance with the Cochrane Collaboration guidelines. The following medical information sources were searched: Medline (via PubMed), Embase (via Ovid), The Cochrane Library. Results: From 241 citations, 13 studies were included in this review. All included studies had a low risk of bias. The faecal immunochemical test is highly specific in all analysed populations ranging from 85% to 97%. In most of the found studies, sensitivity is over 75%. The faecal immunochemical test screening also determines a reduction in death (10–59%) due to colorectal cancer. Conclusions: The faecal immunochemical test is an effective and cost-effective method of conducting population-wide colorectal cancer screening. It is an alternative or complementary to other screening tests, including colonoscopy.

Keywords